| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 34.39B | 48.47B | 27.88B | 22.55B | 7.02B | 3.71B |
| Gross Profit | 31.54B | 43.48B | 25.35B | 15.95B | 6.51B | 3.43B |
| EBITDA | 5.13B | 7.09B | 4.08B | 4.44B | 957.92M | -1.49B |
| Net Income | 2.90B | 4.60B | 2.61B | 3.30B | 534.19M | -1.83B |
Balance Sheet | ||||||
| Total Assets | 66.50B | 69.21B | 67.17B | 23.21B | 24.65B | 12.04B |
| Cash, Cash Equivalents and Short-Term Investments | 6.29B | 7.52B | 7.51B | 3.38B | 4.28B | 2.40B |
| Total Debt | 31.15B | 29.56B | 31.83B | 11.83B | 17.24B | 9.88B |
| Total Liabilities | 38.44B | 37.05B | 38.85B | 16.32B | 21.74B | 11.84B |
| Stockholders Equity | 28.06B | 32.16B | 28.33B | 6.88B | 2.91B | 192.60M |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 5.27B | 3.80B | 7.50B | -110.27M | -7.82B |
| Operating Cash Flow | 0.00 | 5.81B | 4.29B | 7.74B | -109.96M | -7.82B |
| Investing Cash Flow | 0.00 | -2.13B | -3.88B | -1.66B | -728.20M | -415.30M |
| Financing Cash Flow | 0.00 | -3.70B | 4.04B | -6.94B | 2.19B | 8.80B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | ¥228.17B | 8.58 | ― | 2.67% | 8.13% | 7.00% | |
67 Neutral | ¥40.47B | 8.75 | ― | 1.60% | 73.84% | 27.48% | |
65 Neutral | ¥158.96B | 9.30 | 14.78% | 2.95% | 16.84% | 22.03% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | ¥923.60B | 9.73 | 11.06% | 2.88% | 8.32% | 24.62% | |
58 Neutral | ¥152.98B | 14.03 | 8.95% | 3.39% | 20.87% | 16.79% | |
47 Neutral | ¥40.59B | 31.59 | ― | 3.75% | -4.28% | -60.96% |